The joint venture will combine Smart Resilin’s resilin process technology and Acies Bio’s expertise in genetic, microbiological, and scale-up development.
Recombinant structural proteins are promising alternatives to synthetic plastics due to their thermal and mechanical properties and potential for biodegradability. Most recombinant proteins produced today are silk-based and significantly less resilient. Resilin’s resistance is around 92%, compared to 35% for silk, and resilin is cheaper and easier to produce.
“Partnering with Smart Resilin was an easy choice once we became aware of the near-perfect elasticity and resilience of the resilin and the prototypes of products that they have created,” Dr. Štefan Fujs, CEO of Acies Bio, says in a press statement. “Companies across the globe are looking for practical, easy, and commercially-available ways to make their products and processes environmentally friendly, all while maintaining a high-quality product. Smart Resilin’s technology makes this a reachable reality for producers, and we are looking forward to being a part of the production and commercialization of this novel product.”